Beta-carotene
Content by: OpenSupplement Editorial Team | Medical review: pending | Last updated: April 13, 2026
TL;DR
Orange carotenoid that converts to vitamin A only as needed, preventing vitamin A toxicity
Original AREDS study showed AMD benefits, but AREDS2 replaced it due to cancer concerns
ATBC and CARET trials found 18% increased lung cancer risk in smokers and asbestos workers
Safe in non-smokers but can cause harmless orange skin tinting at high doses
Monthly cost: $5-10, but lutein/zeaxanthin are better choices for eye health
Best for: nothing specific — dietary sources preferred over supplements
What it is
Beta-carotene is the most well-known member of the carotenoid family — the pigments that give orange and red colors to carrots, sweet potatoes, and autumn leaves. Unlike preformed vitamin A, beta-carotene is converted to vitamin A only when the body needs it, making toxicity virtually impossible. This safety advantage made it an attractive choice for high-dose antioxidant studies in the 1980s and 1990s.
As an antioxidant, beta-carotene can neutralize singlet oxygen and other reactive species, particularly in lipid-rich environments like cell membranes. This property led researchers to include it in the original AREDS formula for macular degeneration, where oxidative stress plays a key role in disease progression. However, isolated beta-carotene supplementation turned out to have a dark side that wasn't apparent from dietary studies.
The story of beta-carotene illustrates an important principle in nutrition science: nutrients often work differently in isolation than they do in food. Carrots and sweet potatoes contain beta-carotene alongside dozens of other carotenoids and protective compounds, while supplements typically provide just the isolated molecule at doses far higher than found in any diet.
What the research says
Success in original AREDS — Beta-carotene (15mg daily, equivalent to 25,000 IU vitamin A activity) was a key component of the original AREDS formula [1] that reduced advanced AMD progression by 25% over 6 years. The antioxidant combination worked, and beta-carotene appeared to contribute to this success.
Safety concerns emerged — However, concurrent cancer prevention trials revealed troubling results. The ATBC study [3] found an 18% increase in lung cancer among male Finnish smokers taking beta-carotene supplements. The CARET trial confirmed this risk in smokers and asbestos workers, leading to early trial termination.
Successful replacement in AREDS2 — The AREDS2 investigators [2] tested whether removing beta-carotene and adding lutein/zeaxanthin would maintain efficacy while improving safety. The results were reassuring: the lutein/zeaxanthin version worked just as well as the original formula, proving beta-carotene wasn't essential for AMD protection.
Current recommendation — Beta-carotene is no longer recommended for AMD supplementation. The current evidence-based approach uses lutein (10mg) and zeaxanthin (2mg) instead, providing targeted retinal antioxidant support without the lung cancer risk in smokers.
DISCLAIMER: The information on this page is for educational purposes only and has not been evaluated by the Food and Drug Administration. This content is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
This page may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. Learn more.
Beta-carotene on Amazon
Safety
Beta-carotene's safety profile is split between smokers and non-smokers. The ATBC trial showed an 18% increased lung cancer risk in male smokers taking 20mg daily, while the CARET study found similar risks in both male and female smokers plus asbestos workers [3]. The mechanism appears to involve beta-carotene's pro-oxidant effects in the high-oxygen environment of smoker's lungs, where it can actually promote rather than prevent oxidative damage.
For non-smokers, beta-carotene appears much safer. The main side effect is carotenemia — harmless orange-yellow skin discoloration that resolves when supplementation stops. This typically occurs with doses above 30mg daily and affects palms and soles first. Unlike vitamin A toxicity, beta-carotene doesn't cause liver problems or birth defects because conversion to vitamin A is tightly regulated.
Interactions
Cholestyramine and other bile acid sequestrants — moderate interaction. Can reduce beta-carotene absorption. Orlistat (weight loss medication) — moderate interaction. Reduces absorption of fat-soluble carotenoids. Alcohol — minor interaction. Chronic heavy drinking may reduce beta-carotene levels and conversion to vitamin A. Mineral oil — moderate interaction. Can reduce absorption when taken together. Generally has a low interaction profile compared to many supplements.
Dosing
Historical AREDS dose — 15mg (25,000 IU vitamin A equivalent) daily, but this is no longer recommended due to lung cancer risk in smokers. If supplementing — limit to 3-6mg daily, preferably from mixed carotenoid formulations rather than isolated beta-carotene. Food sources preferred — one large carrot provides about 5mg beta-carotene naturally. Take with fat-containing foods for better absorption. Smokers should avoid — completely avoid beta-carotene supplements if you smoke or have significant asbestos exposure history.
Cost
Beta-carotene supplements are inexpensive, typically $5-10 monthly. Basic capsules (25,000 IU) cost around $5-8 per month, while mixed carotenoid formulations with beta-carotene, lycopene, and lutein run $10-15 monthly. However, given the safety concerns and availability of better alternatives (lutein/zeaxanthin for eye health), spending money on beta-carotene supplements isn't recommended. You'll get better value and safety from eating carotenoid-rich foods like carrots, sweet potatoes, and leafy greens, or choosing targeted supplements like lutein for specific health goals.
The bottom line
Beta-carotene had its moment in the supplement spotlight, but that moment has passed. While it played a role in the original AREDS eye formula, safer and equally effective alternatives now exist. The lung cancer risk in smokers is a serious concern that can't be ignored, and even non-smokers are better served by getting carotenoids from food or more targeted supplements. If you're interested in eye health, choose lutein and zeaxanthin instead. If you want antioxidant protection, eat a colorful diet rich in fruits and vegetables rather than relying on isolated beta-carotene supplements. The supplement industry has moved on from beta-carotene, and so should you.
References
- Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-36.
- Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-15.
- The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-35.
Sources for this page include published meta-analyses, systematic reviews, and NIH dietary supplement fact sheets. All claims reflect the evidence as of early 2026.
This is not medical advice. Consult your healthcare provider before starting any supplement, especially if you take medications.